MTOR and breast carcinoma: Dysregulation of mTOR signaling pathway, which is due to genetic variation of several key genes, has bene observed in different types of cancers, such as urothelial bladder cancer[11], breast cancer[12], hepatocellular carcinoma[13] and lung cancer[14].